NVTR | tickerfilter.com

Fundamental analysis

17%

Profitability 0%

Dept financing 15%

Liquidity 75%

Performance 20%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0 0%

1 Month

0 0%

3 Months

0 0%

6 Months

0 0%

1 Year

0 0%

2 Year

0 0%

Key data

Stock price

$0.13

P/E Ratio

N/A

DAY RANGE

$0.13 - $0.13

EPS

-$3.06

52 WEEK RANGE

$0.08 - $20.85

52 WEEK CHANGE

-$98.86

MARKET CAP

3.579 M

YIELD

N/A

SHARES OUTSTANDING

17.885 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.00

PUBLIC FLOAT

$17,201,811

AVERAGE 10 VOLUME

$4,978,504

AVERAGE 30 VOLUME

$2,075,059

Company detail

CEO: Fred B. Parks
Region: US
Website: http://www.nuvectramed.com
Employees: 197
IPO year: -

Issue type: Common Stock
Market: NASDAQ
Industry: Medical Specialties
Sector: Health Technology

Nuvectra Corp. is a neurostimulation medical device company, which engages in the development and commercialization of neurostimulation technology platform for treatment of various disorders through stimulation of tissues associated with the nervous systems. It operates through Nuvectra segment. The Nuvectra segment is a neurostimulation company committed to helping physicians improve the lives of people with chronic conditions. The company was founded on November 14, 2008 and is headquartered in Plano, TX.

NVTR - Nuvectra Corp.